ArticleMolecules (Basel, Switzerland)2026
Synthesis and Antibacterial Activity of Novel
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Foodborne diseases remain a major global public health concern. According to the World Health Organization (WHO), contaminated food causes nearly 500,000 deaths annually. Consequently, the development of novel strategies to control foodborne pathogens and prevent microorganism-induced plant diseases remains an important research priority, attracting considerable scientific attention worldwide. This study describes the design and synthesis of novel dihydropyrazolines containing an ethylpiperazine moiety as potential antimicrobial agents. The antibacterial activity of the newly synthesized heterocyclic compounds, along with their corresponding chalcone precursors, was evaluated against Gram-positive and Gram-negative foodborne pathogens and phytopathogenic bacteria. The assessment was performed using a two-step protocol comprising an initial qualitative screening of selected bacterial species, followed by a quantitative evaluation of the inhibitory effects of individual compounds and their combinations. Among the tested compounds, pyrazolines
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.